56 related articles for article (PubMed ID: 8598477)
21. Physical association of complement receptor type 3 and urokinase-type plasminogen activator receptor in neutrophil membranes.
Xue W; Kindzelskii AL; Todd RF; Petty HR
J Immunol; 1994 May; 152(9):4630-40. PubMed ID: 8157977
[TBL] [Abstract][Full Text] [Related]
22. Human urokinase-type plasminogen activator primes neutrophils for superoxide anion release. Possible roles of complement receptor type 3 and calcium.
Cao D; Mizukami IF; Garni-Wagner BA; Kindzelskii AL; Todd RF; Boxer LA; Petty HR
J Immunol; 1995 Feb; 154(4):1817-29. PubMed ID: 7836767
[TBL] [Abstract][Full Text] [Related]
23. Cocapping of the leukoadhesin molecules complement receptor type 3 and lymphocyte function-associated antigen-1 with Fc gamma receptor III on human neutrophils. Possible role of lectin-like interactions.
Zhou M; Todd RF; van de Winkel JG; Petty HR
J Immunol; 1993 Apr; 150(7):3030-41. PubMed ID: 7681086
[TBL] [Abstract][Full Text] [Related]
24. Modeling the influence of ectodomain affinities on the spatial distribution of membrane receptors.
Weinand RG; Rosenspire AJ; Petty HR
J Theor Biol; 1999 Mar; 197(2):217-25. PubMed ID: 10074395
[TBL] [Abstract][Full Text] [Related]
25. Participation of the urokinase-type plasminogen activator receptor (uPAR) in neutrophil transendothelial migration.
Pliyev BK; Antonova OA; Menshikov M
Mol Immunol; 2011 May; 48(9-10):1168-77. PubMed ID: 21470685
[TBL] [Abstract][Full Text] [Related]
26. Urokinase-type plasminogen activator receptor reversibly dissociates from complement receptor type 3 (alpha M beta 2' CD11b/CD18) during neutrophil polarization.
Kindzelskii AL; Laska ZO; Todd RF; Petty HR
J Immunol; 1996 Jan; 156(1):297-309. PubMed ID: 8598477
[TBL] [Abstract][Full Text] [Related]
27. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
Plesner T; Behrendt N; Ploug M
Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
[TBL] [Abstract][Full Text] [Related]
28. CD87 (urokinase-type plasminogen activator receptor), function and pathology in hematological disorders: a review.
Béné MC; Castoldi G; Knapp W; Rigolin GM; Escribano L; Lemez P; Ludwig WD; Matutes E; Orfao A; Lanza F; van't Veer M;
Leukemia; 2004 Mar; 18(3):394-400. PubMed ID: 14671631
[TBL] [Abstract][Full Text] [Related]
29. Role of the lectin domain of Mac-1/CR3 (CD11b/CD18) in regulating intercellular adhesion.
Ross GD
Immunol Res; 2002; 25(3):219-27. PubMed ID: 12018461
[TBL] [Abstract][Full Text] [Related]
30. Beta 2 (CD11/CD18) integrins can serve as signaling partners for other leukocyte receptors.
Todd RF; Petty HR
J Lab Clin Med; 1997 May; 129(5):492-8. PubMed ID: 9142045
[TBL] [Abstract][Full Text] [Related]
31. Plasminogen activation by receptor-bound urokinase.
Ellis V; Danø K
Semin Thromb Hemost; 1991 Jul; 17(3):194-200. PubMed ID: 1665584
[No Abstract] [Full Text] [Related]
32. Interactions of integrins with their partner proteins in leukocyte membranes.
Petty HR; Worth RG; Todd RF
Immunol Res; 2002; 25(1):75-95. PubMed ID: 11868935
[TBL] [Abstract][Full Text] [Related]
33. Biological significance of the expression of urokinase-type plasminogen activator receptors (uPARs) in brain tumors.
Mohanam S; Gladson CL; Rao CN; Rao JS
Front Biosci; 1999 Feb; 4():D178-87. PubMed ID: 9989951
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]